tirzepatide explosive diarrhea and Bowel Movements: Managing Digestive Effects Weight-Loss Drug Zepbound Is Being

Because the drug acts on gut hormone receptors and slows gastric emptying, the most commonly reported adverse effects in Phase 2 trials include: Nausea (particularly during dose escalation) Vomiting Diarrhoea Constipation Decreased appetite These effects were generally described as mild to moderate in severity and tended to diminish over time

When to Seek Medical Support and Personalized Dose Management Contact your healthcare provider if diarrhea persists beyond 12 weeks of stable dosing, occurs multiple times daily with severe urgency, causes dehydration (dark urine, dizziness, extreme thirst), or contains blood or mucus

Source: RxSpan MD's official website

However, it never received FDA approval because the results, while positive, weren't dramatic enough to meet regulatory thresholds for an obesity drug